Welcome!
IFR
Temasek's Ion Investments to divest stake in South Korean pharma for $1.35b block deal
SINGAPORE (Mar 7): Ion Investments, which is controlled by Temasek Holdings of Singapore, is selling part of its stake in South Korean pharmaceutical company Celltrion and distributor Celltrion Healthcare, IFR reported on Tuesday, citing a term sheet.
March 07, 2018
Singtel hires three banks for up to US$2.5 bil NetLink IPO, says IFR
(Nov 18): Singapore Telecommunications hired three banks to manage an initial public offering (IPO) of up to US$2.5 billion ($3.6 billon) for its broadband subsidiary NetLink Trust, IFR reported late on Thursday, citing people close to the deal.
November 18, 2016